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Inflammation in the absence of infection (sterile inflammation) contributes to acute injury
and chronic disease. Cerebral ischemia is a devastating condition in which the primary
injury is caused by reduced blood supply and is therefore sterile. The cytokine interleukin-
1β (IL-1β) is a key contributor to ischemic brain injury and central inflammatory responses.
The release of IL-1β is regulated by the protease caspase-1, and its activating complex, the
inflammasome. Of the known inflammasomes the best characterized, and one that is per-
ceived to sense sterile injury is formed by a pattern recognition receptor called NOD-like
receptor pyrin domain containing three (NLRP3). A key feature of NLRP3-inflammasome
dependent responses in vitro in macrophages is the requirement of an initial priming stim-
ulus by a pathogen (PAMP), or damage associated molecular pattern (DAMP) respectively.
We sought to determine the inflammatory responses of NLRP3-activating DAMPs on brain
derived mixed glial cells in the absence of an initial priming stimulus in vitro. In cultured
mouse mixed glia the DAMPs ATP, monosodium urate, and calcium pyrophosphate dehy-
drate crystals had no effect on the expression of IL-1α or IL-1β and induced release only when
the cells were primed with a PAMP. In the absence of priming, these DAMPs did however
induce inflammation via the production of IL-6 and CXCL1, and the release of the lysosomal
protease cathepsin B. Furthermore, the acute phase protein serum amyloid A (SAA) acted
as a priming stimulus on glial cells resulting in levels of IL-1 expression comparable to those
induced by the PAMP lipopolysaccharide. In vivo, after cerebral ischemia, IL-1 production
contributed to increased IL-6 and CXCL1 since these cytokines were profoundly reduced in
the ischemic hemispheres from IL-1α/β double KO mice, although injury-induced cytokine
responses were not abolished.Thus, DAMPs augment brain inflammation by directly stim-
ulating production of glial derived inflammatory mediators. This is markedly enhanced by
DAMP-induced IL-1-release-dependent responses that require a sterile endogenous priming
stimulus such as SAA.
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INTRODUCTION
Interleukin-1β (IL-1β) is a key pro-inflammatory cytokine that is
central to the damaging inflammatory processes that accompany
sterile disease (Dinarello, 2011). This is particularly true after an
acute brain injury such as cerebral ischemia, or stroke, where IL-
1β is established as a major contributor to damage (Brough et al.,
2011). It is produced during disease or after an injury as an inac-
tive precursor (pro-IL-1β) by cells of the innate immune system
such as macrophages, or in diseases of the central nervous system
(CNS), by microglia (Denes et al., 2008). In order for it to exert any
biological effects it must be cleaved into an active molecule and
released from the cell whereby it can act on the type I IL-1 receptor
(IL-1RI) on responsive cells (Luheshi et al., 2009). A key protease
required for the processing of pro-IL-1β is caspase-1. The activ-
ity of caspase-1 is regulated by its recruitment to multi-molecular
scaffolds called inflammasomes following an inflammatory stress
(Schroder and Tschopp, 2010). Inflammasomes are composed of a
cytosolic pattern recognition receptor (PRR), pro-caspase-1, and,
depending on the PRR, an adaptor molecule. The best character-
ized inflammasome forming PRR, and the one most implicated
as a sensor of sterile injury, is NOD-like receptor pyrin domain
containing three (NLRP3; Cassel and Sutterwala, 2010; Schroder
and Tschopp, 2010). NLRP3 can be activated by a diverse array
of disease associated molecules, where it oligomerizes with the
adaptor ASC (apoptosis-associated speck-like protein containing
a caspase recruitment domain) and caspase-1 to form the NLRP3-
inflammasome, resulting in the processing of pro- to mature IL-1β
and its release.
The release of IL-1β is considered to be a two step process (Hor-
nung and Latz, 2010; Lopez-Castejon and Brough, 2011). IL-1β is
not normally expressed and so its expression must be induced.
Stimuli that do this are pathogen associated molecular patterns
(PAMPs) or damage associated molecular patterns (DAMPs; Chen
and Nunez, 2010; Takeuchi and Akira, 2010). PAMPs are motifs
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carried by pathogens, such as bacterial endotoxin (or lipopolysac-
charide, LPS) of Gram negative bacteria, and DAMPs are endoge-
nous molecules modified during disease or that are released by
necrosis. Stimuli that prime macrophages in this way are however
generally inefficient secretion stimuli for IL-1β and the primed
cells are required to encounter an additional PAMP or DAMP
stimulus that triggers formation of the inflammasome, activation
of caspase-1, and subsequently the processing and secretion of IL-
1β. This comes from an extensive literature on macrophages, and
although there is evidence that microglia respond in a similar way
to PAMP and DAMP stimulation (Brough et al., 2002; Halle et al.,
2008), these responses have yet to be fully characterized. Not only
are microglia a unique cell type originating from the yolk sac that
are self-renewing throughout life (Ginhoux et al., 2010), but the
brain is also protected by the BBB in the absence of injury, which
keeps microglia isolated from potential blood-derived priming
stimuli. In addition, inflammatory events triggered by DAMPs,
other than IL-1 expression or release, have not been explored in
glial cells previously.
The effects of NLRP3-activating DAMPs are commonly asso-
ciated with IL-1 and on primed cells (Hornung and Latz, 2010).
This is at least in part because NLRP3 expression is itself depen-
dent upon priming (Bauernfeind et al., 2009). However, in many
situations of acute injury, where there is rapid and localized loss
of tissue (such as cerebral ischemia for example) there will be
an abundance of DAMPs that may stimulate cells that have not
been subject to an initial priming stimulus. LPS (often used to
prime cells in vitro) is unlikely to be present in vivo during ster-
ile injury and endogenous priming stimuli in the brain remain
poorly characterized. DAMPs such as monosodium urate (MSU),
and calcium pyrophosphate dehydrate (CPPD) crystals induce the
production of the pro-inflammatory cytokine IL-6 in monocytes
(Guerne et al., 1989) and osteoblast like cells (Bouchard et al.,
2002) in the absence of a priming stimulus. MSU is also known
to act as a potent adjuvant in driving adaptive immune responses
independently of the NLRP3-inflammasome (Kool et al., 2011)
and potentially dependent upon Syk kinase (Ng et al., 2008).
Inflammatory responses in the brain (after cerebral ischemia for
example) may be influenced by both local DAMPs and circulat-
ing inflammatory mediators once the breakdown of the BBB has
occurred. As acute brain injury is associated with a marked cen-
tral inflammatory response the aim of this research was to identify
the inflammatory responses of glial cells, inflammatory cells of the
CNS, to key mediators of sterile injury, NLRP3-activating DAMPs,
in the absence of cell priming, and in the presence of a relevant
endogenous priming stimulus.
MATERIALS AND METHODS
MATERIALS
DMEM culture media was purchased from Sigma (UK). Fetal
bovine serum (FBS), glutamine, and a streptomycin/penicillin
antibiotic solution were all purchased from Invitrogen (UK).
Bacterial LPS (Escherichia coli 026:B6), Poly(IC), and ATP were
purchased from Sigma (UK). MSU and CPPD crystals were from
Invivogen (UK). Serum amyloid A (SAA) was purchased from
PeproTech (UK). All primers for qPCR were purchased from
Qiagen (UK).
MIDDLE CEREBRAL ARTERY OCCLUSION, PERFUSION, AND TISSUE
HOMOGENIZATION
We induced cerebral ischemia by middle cerebral artery occlu-
sion (MCAo) as described previously (Denes et al., 2010a). Briefly,
C57BL/6J mice (Harlan Olac) or IL-1αβ-deficient (IL-1αβ dou-
ble KO) mice, weighing 26–32 g were anesthetized with isoflurane
and were subjected to MCAo for 60 min using an intraluminal
filament (180µm diameter, left side occluded) followed by 24 h
reperfusion. After transcardial perfusion with saline, brains were
collected, and homogenized as described previously (Chapman
et al., 2009). Protein concentrations were calculated using BCA
assay (Pierce/Thermo Fisher Scientific). Some mice were perfused
with 4% paraformaldehyde (PFA), and following post-fixation in
PFA and cryoprotection in sucrose, brain sections were cut on
a sledge microtome for immunohistochemistry and cresyl-violet
staining. All animal procedures were performed under the Univer-
sity of Manchester project license number (40/3076) and adhered
to the UK Animals (Scientific Procedures) Act (1986).
IMMUNOHISTOCHEMISTRY
Immunostaining was performed on free-floating brain sections as
described (Denes et al., 2010a). After blocking with 2% normal
donkey serum in PBS containing 0.3% Triton X-100, rabbit anti-
Iba1 (WAKO, Germany) and rat anti-CD45 (Serotec, UK) anti-
bodies were incubated overnight. Antigens were visualized using
appropriate fluorochrome (Alexa 594,Alexa 488)-conjugated don-
key secondary antibodies (Invitrogen). Mounted brain sections
were coverslipped with ProLong mounting medium (Invitrogen)
and analyzed on an Olympus BX51 microscope using a Coolsnap
ES camera (Photometrics) through MetaVue software (Molecular
Devices). CD45 and Iba 1 positive cells were quantified by counting
six separate sections from the ipsilateral and contralateral hemi-
spheres (striatum and cortex). The numbers of Iba 1 positive cells
expressing CD45 were recorded for both hemispheres.
CELL CULTURE
Mixed glia were cultured from C57Bl/6J at post-natal day 1–4 as
described previously (Pinteaux et al., 2002). Whole brains were
dissected into DMEM with 10% FBS v/v and 1% P/S. Meninges
were removed and cells dissociated by trituration prior to seeding
at a density equivalent to one brain/60 cm2. The culture medium
was changed twice a week until cultures reached confluency (14–
20 days). These cultures are composed of 78% astrocytes,12% O2A
progenitor cells, and 10% microglia (Pinteaux et al., 2002). Cul-
tures were treated with LPS (1µg/ml), poly(IC; 50µg/ml), ATP
(5 mM), MSU (250µg/ml), CPPD (250µg/ml), or SAA (0.03–
3µg/ml) for 24 h. Cultures subjected to PAMP and DAMP stim-
ulation were treated with LPS or SAA for 24 h followed by ATP,
MSU, or CPPD for 1 h.
QUANTITATIVE REAL-TIME PCR
RNA was extracted from cultured mixed glia using the TRIzol®
method (Invitrogen) and reverse transcribed to cDNA using
MMLV reverse transcriptase according to the manufacturer’s
instructions (Invitrogen). Specific primers for IL-1β, IL-1α,
caspase-1, NLRP3, ASC, iNOS, IL-6, TNFα, CXCL1, and CXCL12
were purchased from Qiagen (QuantiTech Primer Assays) and
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qPCR was performed using Power SYBR® Green PCR mastermix
(Applied Biosystems) and SDS v2.3 (Applied Biosystems). For each
primer set the CT threshold was set manually to achieve a slope
efficiency of >99% and a single product on melt curve analysis.
RNA from LPS-treated J774 macrophages was used to create a stan-
dard curve and gene expression was calculated using the relative
standard curve method. Data were normalized to expression levels
of the housekeeping gene SDHA (QuantiTech Primer Assays, Qia-
gen) across each treatment and fold change was expressed relative
to basal RNA levels from untreated mixed glia.
DETECTION OF CYTOKINES BY ELISA
Measurement of key inflammatory cytokines (IL-1β, IL-1α, IL-6,
CXCL1) released into the culture supernatant or expressed in the
lysate was performed using specific ELISAs (R&D Systems, UK)
according to manufacturers guidelines.
DETECTION OF CYTOKINES BY ELISA AND CYTOMETRIC BEAD ARRAY
Measurement of cytokines released into the culture supernatant or
expressed in the lysate was performed using specific ELISAs (R&D
Systems, UK) according to manufacturer’s guidelines. Key inflam-
matory cytokines (IL-1β, IL-1α, IL-6, CXCL1) were measured
in all tissues examined using appropriate cytometric bead array
(CBA) Flex Sets (BD Biosciences) according to the manufacturer’s
protocol.
FLOW CYTOMETRIC ANALYSIS
Cultured mixed glia were resuspended using 0.5 mM EDTA in PBS.
The following fluorochrome-labeled monoclonal antibodies were
applied according to manufacturer’s instructions: PE conjugated
anti-CD11c (1:100, eBioscience), APC conjugated anti-MHCII
(1:200, eBioscience), FITC conjugated anti-CD11b (1:200, eBio-
science), and PerCP-Cy5.5 conjugated anti-CD45 (1:500, eBio-
science). The surface expression of these markers were analyzed
using CyAn advanced flow cytometer (Beckman Coulter) and
Summit v4.3 software (Dako). Microglia were gated for analysis
based on co-expression of CD11b and CD45.
WESTERN BLOTTING
Following the experiment supernatants were harvested and pre-
pared in sample buffer containing 1% β-mercaptoethanol. Sam-
ples were boiled and then electrophoresed on 12% SDS-acrylamide
gels. Proteins were subsequently transferred onto nitrocellulose
membrane and blotted using polyclonal sheep anti-mouse IL-1β
(1:1000 in 5% milk, NIBSC, UK), or polyclonal goat anti-mouse
cathepsin B (1:500, R&D Systems). The membrane was then
stained with polyclonal rabbit anti-sheep IgG horse radish peroxi-
dise (HRP) conjugate for IL-1β (1:2000 in 5% milk, Dako, UK), or
with HRP-conjugated rabbit anti-goat IgG for cathepsin B (1:1000
in 5% milk, Dako, UK), with subsequent exposure using enhanced
chemi-luminescence (ECL) reagents (Amersham, UK).
GEL ZYMOGRAPHY
Released gelatinase activity was assessed by gelatin-substrate
zymography as previously described (Kleiner and Stetler-
Stevenson, 1994). Briefly, serum free supernatants from treated
cultured mixed glia were mixed with an equal volume of load-
ing buffer (10% SDS, 50% glycerol, 400 mM Tris-HCl pH 6.8,
250µg/ml bromophenol blue). All samples were loaded neat onto
8% zymography gels except for one of the ATP-treated super-
natants (+∗) which was diluted 1:3. Following electrophoresis,
gels were washed in 2.5% Triton X-100 to remove SDS. Proteinases
were renatured in activity buffer (50 mM Tris-HCl pH 7.5, 5 mM
CaCl2, 5µM ZnCl2, 0.02% NaN3) for 96 h at 37˚C prior to stain-
ing in 0.5% Coomassie Brilliant Blue R-250 in 40% methanol and
10% acetic acid for 1 h at rt. Gels were destained at rt in 10%
acetic acid, 10% methanol until clear bands appeared. Molecular
weight of bands was estimated against molecular weight markers
(BioRad).
DATA ANALYSIS
All quantitative assessments were performed in a blinded manner.
Unless stated otherwise, for two groups paired t -test (two-tailed),
for three or more groups one-way or two-way analysis of variance
(ANOVA) followed by Bonferonni’s post hoc multiple- or paired-
comparison were used. All data are expressed as mean± SD.
***P < 0.001, **P < 0.01, *P < 0.05.
RESULTS
As discussed above, NLRP3 is proposed as a sensor of sterile injury
and disease and recognizes a wide range of structurally diverse
DAMPs (Cassel and Sutterwala, 2010). We selected three of the
best characterized NLRP3-activating DAMPs for our investiga-
tion into the effects of cell priming. ATP activates NLRP3 via
its activation of cell surface P2X7 receptors (Mariathasan et al.,
2006). MSU and CPPD crystals, inflammatory drivers of gout, and
pseudogout respectively also activate the NLRP3-inflammasome
(Martinon et al., 2006). Uric acid crystals are also suggested to
be a general inflammatory signal released from dead and dying
cells (Kono et al., 2010). We initially looked at the effects of these
NLRP3-activating DAMPs on cell priming itself. Primary cultures
of mouse mixed glia (composed of astrocytes and microglia; Pin-
teaux et al., 2002) were treated with ATP, MSU, or CPPD crystals
for 4 h after which lysates were harvested and analyzed by qPCR for
the expression of markers of inflammatory cell priming (Figure 1).
As a positive control cultures were treated with the PAMP LPS. We
initially investigated the effects of these DAMPs and LPS on the
expression of genes typically associated with the inflammasome
and priming e.g., IL-1β (Figure 1Ai), IL-1α (Figure 1Bi), caspase-
1 (Figure 1Ci), NLRP3 (Figure 1Di), and ASC (Figure 1Ei). In
general, DAMPs had no effect on the expression of these genes
except for CPPD crystals, where a significant increase in the
expression of IL-1β and IL-1α was observed (Figures 1Ai,Bi).
LPS stimulation increased the expression of all genes, including
caspase-1 (Figure 1C) and NLRP3 (Figure 1D), but did not affect
ASC, whose expression did not change with any treatment except
with CPPD crystals where a significant decrease was observed
(Figure 1E).
In order to determine whether these NLRP3-activating DAMPs
were capable of stimulating a more general inflammatory response
we extended our study on gene expression to include additional
inflammatory genes such as iNOS (Figure 1F), IL-6 (Figure 1G),
TNFα (Figure 1H), and CXCL1 (Figure 1I). Again, DAMPs had
no effect, with the exception of CPPD crystals on the expression
of iNOS (Figure 1F), IL-6 (Figure 1G), and CXCL1 (Figure 1I),
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FIGURE 1 | Effects of DAMPs on the expression of pro-inflammatory
genes in cultured mixed glia. mRNA levels of pro-inflammatory genes were
measured by qPCR after 4 h exposure to the NLRP3-activating DAMPs ATP
(5 mM), MSU, and CPPD (both 250µg/ml) (Ai) or the PAMP LPS (1µg/ml)
(Aii). Data were normalized to expression levels of the housekeeping gene
SDHA across each treatment and fold change was expressed relative to basal
RNA levels from untreated mixed glia. The genes analyzed were IL-1β (A),
IL-1α (B), caspase-1 (C), NLRP3 (D), ASC (E), iNOS (F), IL-6 (G), TNFα (H), and
CXCL1 (I). Data are pooled samples from at least five separate experiments.
**P <0.01, *P < 0.05, vs. untreated.
whilst LPS induced a robust response across all genes tested.
These data suggest that at the level of gene expression, and within
the limits of the genes investigated in this study, and with the
exception of CPPD, NLRP3-activating DAMPs have a negligible
effect.
We then investigated protein levels in DAMP treated mixed glial
cultures for IL-1β, IL-1α, IL-6, and CXCL1, which we have previ-
ously reported to be upregulated in response to focal ischemic
injury in both the plasma and peripheral tissues, and in the brain
(Chapman et al., 2009; Denes et al., 2010a; Figure 2). After 24 h
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NLRP3-activating DAMPs induced no increase in the protein lev-
els of IL-1β (Figure 2Ai) or IL-1α (Figure 2Bi), whilst MSU and
CPPD did induce significant increases in the production of IL-6
(Figure 2Ci) and CXCL1 (Figure 2Di). Although raised at 24 h the
effects of ATP on IL-6 and CXCL1 levels were not significant, but
were when we investigated the earlier time point of 4 h (Figure 2E).
LPS induced a robust increase in the levels of all proteins examined
(Figure 2). The production of inflammatory mediators by DAMPs
alone suggest that they are capable of inducing an inflammatory
response, albeit not as robust when compared to the effects of
typical PAMPs such as LPS. How these DAMPs act to induce this
inflammatory response is not known. None of the DAMPs tested
here are reported to act as ligands for toll-like receptor (TLR).
However, as mentioned in the introduction MSU can induce Syk
kinase signaling (Ng et al., 2008). These DAMPs also caused some
cell death within our cultures (data not shown) and so it is pos-
sible that this contributed to the effects on cytokine production
observed. Microglia can upregulate CD11c and MHCII markers
on the cell surface after cerebral ischemia, resulting in a phenotype
resembling that of dendritic cells (Felger et al., 2010). We investi-
gated whether PAMPs and DAMPs can directly activate an antigen-
presenting phenotype in microglia. Flow cytometry showed that
LPS induced an activation of cell surface CD11c and MHCII in
microglia, whilst DAMPs alone had no effect (Figure 3). These
data suggest that the NLRP3-inflammasome activating DAMPs
investigated here, when applied alone, do not act as a priming
stimulus for microglial antigen presentation.
These DAMPs are known to engage the NLRP3-inflammasome
and to activate caspase-1 resulting in the processing and release of
IL-1β from primed cells. Although much of the literature on IL-
1 secretion comes from work on peripheral macrophages, PAMP
and DAMP-dependent IL-1 responses from microglia have been
reported (e.g., Brough et al., 2002; Halle et al., 2008). The limited
effects of these DAMPs observed so far was not due to their use at
an insufficient concentration since priming of mixed glial cultures
with LPS followed by treatment with ATP, MSU, or CPPD induced
caspase-1 activation and the release of mature IL-1β (Figure 4A),
and IL-1α (Figure 4B).
A key step during cerebral ischemia is the early breakdown of
the BBB, although it is not known whether this is facilitated by the
release of DAMPs from dying cells. Therefore we investigated the
effects of DAMPs on the release of cathepsin B and of gelatinases
which have been reported to be released following ATP-dependent
activation of the P2X7 receptor in the absence of PAMP priming
(Gu and Wiley, 2006; Lopez-Castejon et al., 2010), and which con-
tribute to BBB damage after brain injury (Candelario-Jalil et al.,
2009). In cultures of mixed glia ATP, MSU, CPPD, and LPS all
induced the release of cathepsin B mature single chain (28–30 kDa)
form (Figure 5A). Gelatin gel zymography of supernatants from
cultures of mixed glia revealed that pro-MMP2 (72 kDa) was con-
stitutively released under control conditions and that treatment
of cultures with LPS, or with the DAMPs MSU or CPPD had
no effect on released gelatinase activity (Figure 5B). P2X7 recep-
tor activation in monocytes induces the release of active MMP9
(Gu and Wiley, 2006), and here in our cultures of mixed glia ATP-
treatment induced a massive increase in released gelatinase activity
(Figure 5B).
FIGURE 2 | Effects of DAMPs on pro-inflammatory protein levels in
cultured mixed glia. Protein levels of pro-inflammatory mediators were
measured by specific ELISAs after 24 h (A–D) or 4 h (E) exposure to the
NLRP3-activating DAMPs ATP (5 mM), MSU, and CPPD [both 250µg/ml;
(Ai)] or the PAMP LPS [1µg/ml; (Aii)]. The proteins analyzed were IL-1β (A),
IL-1α (B), IL-6 (C,E), CXCL1 (D,E). Data are pooled samples from at least five
separate experiments. ***P <0.001, **P <0.01, *P <0.05, vs. untreated.
Although many DAMPs are reported to activate PRRs of the
TLR family to prime inflammatory responses (Chen and Nunez,
2010), the priming stimulus for inflammasome function in the
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FIGURE 3 | Effects of DAMPs on surface marker expression in microglia
cells. The expression of surface markers of microglia activation MHC class
II (A), and CD11c (B) were measured after 24 h exposure to the
NLRP3-activating DAMPs ATP (5 mM), MSU, and CPPD [both 250µg/ml;
(Bi)] or the PAMP LPS [1µg/ml; (Bii)]. Flow cytometry was used to quantify
surface marker expression. Data are expressed as a percentage of cells
that co-express CD45 and CD11b. Representative dot plots showing the
CD45 and CD11b expressing cell population plus and minus LPS treatment
are also shown (Biii). Data are pooled samples from at least five separate
experiments. ***P <0.001 vs. untreated.
brain in vivo is unknown. BBB breakdown takes place early after
cerebral ischemia allowing the penetration of circulating inflam-
matory mediators into the brain. This coincides with systemic
FIGURE 4 |The effects of PAMPs and DAMPs on the release of IL-1 from
cultured mixed glia. Cultured mixed glia were treated (1 h) with the
NLRP3-activating DAMPs ATP (5 mM), MSU, and CPPD (both 250µg/ml)
plus and minus a 24 h priming stimulus with the PAMP LPS (1µg/ml).
Release of both IL-1β (A) and IL-1α (B) were quantified by ELISA (Ai), and
processing of pro- (31 kDa) to mature (17 kDa) IL-1β in PAMP and DAMP
treated cells was analyzed by Western blot (Aii). Data are pooled samples
from at least five separate experiments. **P <0.01, *P < 0.05 vs.
untreated.
upregulation of acute phase proteins such as SAA, which acts as
an alternative acute phase protein to CRP in mice and is upregu-
lated in plasma as early as 4 h after MCAo (McColl et al., 2007).
Four hours after MCAo in the mouse there is disruption of the
BBB and microglia localized to these areas of focal BBB disruption
express IL-1 (Luheshi et al., 2011), suggesting that plasma derived
factors could provide the priming stimulus. Moreover, SAA is
reported to prime NLRP3-inflammasome dependent responses
in macrophages (Ather et al., 2011; Niemi et al., 2011), and in syn-
ovial fibroblasts (Migita et al., 2012), although its effect on brain
glia is unknown. Treatment of mixed glial cultures with SAA (0.03–
3µg/ml, 24 h) induced the expression of IL-1β (Figure 6A) and
IL-1α (Figure 6B). These cells were effectively primed for inflam-
masome dependent responses as the addition of the DAMP ATP
(5 mM, 1 h) induced a significant release of IL-1β (Figure 6C).
These data suggest the possibility that DAMP-dependent inflam-
masome responses in the brain may be primed by endogenous
plasma constituents.
Since we had found that DAMPs mediated inflammation
directly and also induced IL-1 release from primed glial cells
in vitro, we aimed to investigate the effects of DAMPs on local
pro-inflammatory responses induced by brain injury in vivo in the
absence of IL-1. NLRP3-inflammasome activating DAMPs induce
the release of both IL-1α and IL-1β from primed macrophages
(Gross et al., 2012), and so to investigate the effects of DAMPs
independently of IL-1 stimulated events we subjected WT and
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FIGURE 5 | DAMPs induce the release of proteases from cultured
mixed glia. Cultured mixed glia were treated with the NLRP3-activating
DAMPs ATP (5 mM), MSU, and CPPD (both 250µg/ml) or the PAMP LPS
(1µg/ml) for 24 h. Supernatants were analyzed for the release of mature
Cathepsin B (28–30 kDa) by Western blot (A). To measure the release of
martix metalloproteases by zymography all samples were loaded neat onto
gels except for one of the ATP-treated supernatants (+*) which was diluted
1:3 (B). Blots and gels shown are representative of at least five separate
experiments.
IL-1α/β double KO mice to transient middle cerebral artery occlu-
sion (tMCAo) a model of experimental stroke. Thus use of the
IL-1α/β double KO mice allowed us to dissect DAMP-dependent
responses independently of any IL-1-mediated inflammation. Fol-
lowing tMCAo there was a large lesion in the ipsilateral hemi-
sphere of mice, suggesting that glial cells in this hemisphere
would be exposed to DAMPs (Figure 7Ai). Within this area
there was significant microglial cell activation when compared
to the contralateral hemisphere, observed by increased expres-
sion of Iba1 and CD45 (Figures 7Ai–iii). Twenty four hours
after MCAo IL-6 and CXCL1 were increased in the ipsilateral
hemisphere independently of the presence of IL-1 (P < 0.01 and
0.001, respectively, two-way ANOVA) compared to the contralat-
eral hemisphere (Figures 7B,C). WT mice demonstrated a higher
level of increase (70-fold for IL-6 and 24-fold for CXCL1) than
IL-1α/β KO mice (26-fold for IL-6 and 11-fold for CXCL1), but
CXCL1 was still significantly upregulated in IL-1a/b KO mice in
the ipsilateral hemisphere based on Bonferroni’s post hoc com-
parison following two-way ANOVA (P < 0.05) and the interac-
tion between genotype and hemispheric increase of CXCL1 was
also significant (two-way ANOVA, P < 0.01; Figures 7B,C). IL-1β
and IL-1α levels were undetectable in IL-1α/β KO mice and IL-
1α displayed a significant increase after cerebral ischemia in the
ipsilateral hemisphere (two-way ANOVA followed by Bonferroni’s
post hoc test, P <−0.05, not shown). These data are consistent
with the in vitro data above, suggesting that DAMPs induce a
priming-independent inflammatory response, and once expres-
sion and release of IL-1 takes place, this inflammatory response is
markedly augmented in the brain in vivo.
DISCUSSION
Here, we have analyzed the pro-inflammatory effects of NLRP3-
activating DAMPs in the absence/presence of priming stimuli
in vitro in cultures of mixed glial cells. As a result of our investiga-
tions we propose that in acute brain injury DAMPs can contribute
to brain inflammation via at least three mechanisms: by directly
stimulating the production of glial derived pro-inflammatory
mediators, by contributing to BBB injury through the release of
various proteases, and by inducing IL-1 release from primed cells.
The presence of IL-1 in turn, markedly augments damage-induced
inflammatory responses in vivo.
Inflammation is recognized as a major contributor to the wors-
ening of acute brain injury and inhibiting IL-1 with the receptor
antagonist (IL-1Ra) is protective in experimental models of stroke
(Brough et al., 2011), and has shown promise as a treatment in clin-
ical trials (Emsley et al., 2005). Early after cerebral ischemia (4 h)
the related IL-1 family member IL-1α is expressed by microglia
in areas of brain that will become infarct (Luheshi et al., 2011),
with subsequent expression of IL-1β occurring at later time points
(24 h; Denes et al., 2008). Mice in which both IL-1α and IL-1β have
been deleted (IL-1α/β double KO), but not single gene KOs, have
markedly reduced damage in response to MCAo (Boutin et al.,
2001).
Within an ischemic tissue there will be abundant levels of
DAMPs that may serve to mediate local inflammatory responses.
The inflammatory actions of DAMPs are most often reported as
the ability to stimulate formation of the NLRP3-inflammasome,
thus activating caspase-1 and inducing the release of IL-1β (Cassel
and Sutterwala, 2010). However, in vitro DAMPs are only reported
to achieve this after the cell, typically a macrophage, has been
primed with a PAMP such as LPS (Bauernfeind et al., 2009; Hor-
nung and Latz, 2010). In monocytes and synoviocytes (Guerne
et al., 1989), and osteoblast like cells (Bouchard et al., 2002) release
IL-6 occurs in response to the NLRP3-inflammasome activating
DAMPs MSU and CPPD in the absence of priming. However, to-
date, an investigation of the pro-inflammatory effects of NLRP3-
activating DAMPs in glial cells, in the absence of priming, has
not taken place. Thus, in this study we sought to determine the
pro-inflammatory effects of NLRP3-activating DAMPs in the pres-
ence and absence of PAMPs on inflammatory cells from the brain.
We used cultures of mixed glia, composed mainly of astrocytes
and microglia (Pinteaux et al., 2002). Both microglia and astro-
cytes represent a source of IL-1 in culture (Brough et al., 2002;
Bianco et al., 2009) and from our experiments it was not possible
to identify the relative contribution of each cell type to released
cytokine levels. Given their similarity to macrophages, microglia
are generally considered to be the major source of IL-1 in the
brain after an injury (Denes et al., 2010b), yet astrocytes are also
known to express IL-1β following MCAo in mice (Denes et al.,
2008). It is possible that a contribution from both cellular sources
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FIGURE 6 |The effects of DAMPs on the release of IL-1 from cultured
mixed glia primed with serum amyloid A (SAA). Cultured mixed glia
were treated with the indicated concentration of SAA for 24 h and the
expression of IL-1β (A) and IL-1α (B) was measured in the cell lysate by
ELISA. The NLRP3-activating DAMP ATP (5 mM) was added to the cultures
after a 24 h priming stimulus with SAA (3µg/ml) and released IL-1β was
quantified by ELISA (Ci). And processing of pro- (31 kDa) to mature
(17 kDa) IL-1β was analyzed by Western blot (Cii). Data are pooled samples
from at least five separate experiments. ***P <0.001, **P <0.01,
*P <0.05 vs. untreated.
drives inflammation after brain injury, although further exper-
iments with purified cell cultures, and animal models in which
solely microglia or astrocytes can produce IL-1 are required to test
this.
Entirely consistent with the literature on macrophages, we
found that several well characterized DAMPs (ATP, MSU, and
CPPD crystals), had no effect on IL-1β levels in the absence of
prior PAMP priming (Figures 1, 2, and 4). The results for IL-
1α mirrored the effects of DAMPs on IL-1β, i.e., the DAMPs had
no effect except when added to a PAMP-primed cell when they
induced release (Figures 1, 2, and 4). In contrast, we show that
DAMPs induce IL-6 and CXCL1 release from glia in vitro in the
absence of any priming stimulus, indicating that DAMPs have
a direct pro-inflammatory effect on glial cells independently of
PAMP-induced signals (Figure 2).
This priming-independent inflammatory response was also
observed in vivo after MCAo in IL-1α/β double KO mice
(Figure 7). The priming stimuli for IL-1-dependent responses in
the brain after a stroke are not known. There are a number of
possible candidates however. For example, after disruption of the
BBB plasma derived molecules known to prime IL-1β responses
such as minimally oxidized LDL, and which are associated with
co-morbid diseases like type II diabetes, could prime glia at the
lesion site (Masters et al., 2010). Other plasma derived molecules
include acute phase reactants such as SAA which has also been
reported to prime NLRP3-inflammasome dependent responses
in macrophages (Ather et al., 2011; Niemi et al., 2011), and we
know that 4 h following MCAo in the mouse plasma SAA levels
are elevated (McColl et al., 2007). We showed that SAA was capa-
ble of priming glial cultures to express IL-1α and IL-1β (Figure 6).
Analogous to the PAMP priming observed with LPS, SAA alone
did not induce the release of IL-1, but IL-1β release did occur
after a SAA-primed culture was treated with ATP (Figure 6). In
addition to these examples it is possible that one of a plethora of
DAMPs reported to activate TLRs could provide the priming stim-
ulus (Piccinini and Midwood, 2010). However, our study serves to
highlight that brain inflammatory cells can respond to endoge-
nous priming stimuli to promote IL-1-dependent inflammatory
responses.
We also discovered that treatment of cultured mixed glia
with DAMPs induced the release of cathepsin B, and that the
DAMP ATP induced a massive release of gelatinase activity in the
absence of priming (Figure 5). ATP induced cathepsin B release
from non-primed macrophages results in the in vitro degradation
of extracellular matrix, suggesting its pro-inflammatory action
(Lopez-Castejon et al., 2010). That MSU and CPPD crystals also
induce the release of active cathepsin B from non-PAMP-primed
cells (Figure 5) suggest that this could be a common inflam-
matory mechanism of DAMPs. Furthermore, treatment with a
cathepsin B inhibitor in vivo is neuroprotective following stroke
(Benchoua et al., 2004). The effects of DAMP-induced release of
gelatinases such as MMP9 could be twofold. MMP9 is known to
disrupt the integrity of the BBB following MCAo (McColl et al.,
2008), and is also known to be neurotoxic in neuroinflammatory
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FIGURE 7 |The inflammatory response to cerebral ischemia. Cortical cell
death occurs in the ipsilateral cortex after transient middle cerebral artery
occlusion (tMCAo) [insert (Ai)]. Microglia in this region have a significantly
more activated morphology (Ai,iii) as shown by immunofluorescent staining
for Iba1 (red) and CD45 (green), compared to those from the same region of
the contralateral hemisphere (Aii,iii). At the protein level in vivo, IL-6 (B) and
CXCL1 (C) increase significantly in the ipsilateral cortex of WT mice after
tMCAo. IL-6 and CXCL1 protein levels are significantly attenuated in IL-1α/β KO
mice (B,C). Data are expressed as fold increase over the contralateral
hemisphere, are from a minimum of three independent experiments and
were analyzed by two-way ANOVA followed by a Bonferonni post hoc
analysis. **P <0.01, *P <0.05.
in vitro models (Thornton et al., 2008). The consequence of these
IL-1-independent DAMP effects would be increased production
of inflammatory mediators and acute phase reactants, leukocyte
recruitment,BBB disruption,and the influx of peripheral, systemic
factors.
These data reveal how DAMPs induce inflammatory responses
in the absence of any bacterial infection or products, and may be
relevant to a range of sterile insults in addition to the model of
brain injury used here. These data support a model where DAMPs
released at a site of sterile injury induce the release of cytokines
and proteases that are central to the establishment of an inflam-
matory response. DAMPs also induce the secretion of IL-1α and
IL-1β from primed glia. In turn, the presence of IL-1 enhances
sterile injury-induced inflammatory responses. It is not clear what
primes microglia in vivo during ischemia but it could be one of a
large number of factors, including plasma derived mediators such
as SAA, and remains a subject for future investigation.
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